Figure 3.
Schema describing the presumed drug sensitivities of metastatic ccRCC affecting glandular and non-glandular tissues. ccRCC, clear cell renal cell carcinoma; TKIs, tyrosine kinase inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.